1. A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high‐risk neuroblastoma. Issue 11 (24th May 2020) Authors: Lewis, Elizabeth C.; Kraveka, Jacqueline M.; Ferguson, William; Eslin, Don; Brown, Valerie I.; Bergendahl, Genevieve; Roberts, William; Wada, Randal K.; Oesterheld, Javier; Mitchell, Deanna; Foley, Jessica; Zage, Peter; Rawwas, Jawhar; Rich, Maria; Lorenzi, Elizabeth; Broglio, Kristine; Berry, Do... Journal: International journal of cancer Issue: Volume 147:Issue 11(2020) Page Start: 3152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Binimetinib inhibits MEK and is effective against neuroblastoma tumor cells with low NF1 expression. Issue 1 (December 2016) Authors: Woodfield, Sarah; Zhang, Linna; Scorsone, Kathleen; Liu, Yin; Zage, Peter Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. MBRS-06. THE ROLE OF G-CSF RECEPTOR SURFACE EXPRESSION IN MEDULLOBLASTOMA PATHOGENESIS. Issue 2 (22nd June 2018) Authors: Paul, Megan; Zage, Peter Journal: Neuro-oncology Issue: Volume 20:Issue 2(2018)supplement 2 Page Start: i129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Sociodemographic and clinical characteristics associated with vitamin D status in newly diagnosed pediatric cancer patients. (18th May 2020) Authors: Aristizabal, Paula; Sherer, Michael; Perdomo, Bianca P.; Castelao, Esteban; Thornburg, Courtney D.; Proudfoot, James; Jacobs, Elizabeth; Newfield, Ron S.; Zage, Peter; Roberts, William; Martinez, Maria Elena Journal: Pediatric hematology and oncology Issue: Volume 37:Number 4(2020) Page Start: 314 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗